Polycythemia vera: Scientific advances and current practice

Medicine & Life Sciences

• Polycythemia Vera 100%
• Polycythemia 38%
• Thrombocytosis 23%
• Extramedullary Hematopoiesis 17%
• Erythrocyte Volume 17%
• Myeloproliferative Disorders 15%
• Primary Myelofibrosis 14%
• Mutation 13%
• Erythropoietin 12%
• Bone Marrow 8%
• Phlebotomy 7%
• Leukocytosis 6%
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6%
• Bone Marrow Transplantation 6%
• Hematopoietic Stem Cells 5%
• Point Mutation 5%
• Incidence 5%
• Aspirin 5%
• Protein-Tyrosine Kinases 5%
• In Vitro Techniques 5%
• Hypersensitivity 4%
• Leukemia 4%
• Intercellular Signaling Peptides and Proteins 4%
• Leukocytes 4%
• Histology 4%
• Erythrocytes 4%
• Blood Platelets 4%
• Differential Diagnosis 4%
• Fibrosis 4%
• Therapeutics 2%
• Serum 2%